• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病瘦素缺乏患者中GAD65抗体的患病率。

Prevalence of GAD65 antibodies in lean subjects with type 2 diabetes.

作者信息

Unnikrishnan A G, Singh S K, Sanjeevi C B

机构信息

Department of Endocrinology, Amrita Institute of Medical Sciences, Cochin, Kerala, India.

出版信息

Ann N Y Acad Sci. 2004 Dec;1037:118-21. doi: 10.1196/annals.1337.018.

DOI:10.1196/annals.1337.018
PMID:15699503
Abstract

While type 2 diabetic subjects in developed countries are predominantly obese or overweight, those in India are often nonobese or lean. The reasons for leanness in these subjects has not been well understood. We assessed the prevalence of pancreatic islet autoimmunity in 83 lean adult subjects (BMI < 18.5 kg/m(2)) with type 2 diabetes by measuring antibodies to glutamic acid decarboxylase-65 (GAD Abs). Positivity to GAD Ab was present in 21 (25.3%) subjects. In addition, subjects with GAD Ab positivity were younger and had lower beta cell function (homeostasis model assessment, HOMA) as compared to the GAD Ab-negative group. This suggests that the antibody-positive group could have a slowly progressive form of type 1 diabetes.

摘要

在发达国家,2型糖尿病患者主要是肥胖或超重的,而在印度,这类患者往往不肥胖或体型偏瘦。这些患者体型偏瘦的原因尚未完全明确。我们通过检测谷氨酸脱羧酶65抗体(GAD抗体),评估了83名体重偏轻的成年2型糖尿病患者(体重指数<18.5kg/m²)中胰岛自身免疫的患病率。21名(25.3%)受试者的GAD抗体呈阳性。此外,与GAD抗体阴性组相比,GAD抗体阳性的受试者年龄更小,β细胞功能(稳态模型评估,HOMA)更低。这表明抗体阳性组可能患有缓慢进展型1型糖尿病。

相似文献

1
Prevalence of GAD65 antibodies in lean subjects with type 2 diabetes.2型糖尿病瘦素缺乏患者中GAD65抗体的患病率。
Ann N Y Acad Sci. 2004 Dec;1037:118-21. doi: 10.1196/annals.1337.018.
2
Diagnostic role of antibodies to glutamic acid decarboxylase in latent autoimmune diabetes mellitus in adults.成人隐匿性自身免疫性糖尿病中谷氨酸脱羧酶抗体的诊断作用
Chin Med J (Engl). 1999 Jun;112(6):554-7.
3
Antibodies to pancreatic islet cell antigens in diabetes seen in Southern India with particular reference to fibrocalculous pancreatic diabetes.印度南部所见糖尿病患者中针对胰岛细胞抗原的抗体,特别提及纤维钙化性胰腺糖尿病。
Diabet Med. 1998 Feb;15(2):156-9. doi: 10.1002/(SICI)1096-9136(199802)15:2<156::AID-DIA533>3.0.CO;2-E.
4
Carboxypeptidase-H autoantibodies differentiate a more latent subset of autoimmune diabetes from phenotypic type 2 diabetes among Chinese adults.羧肽酶H自身抗体在中国成年人中可将自身免疫性糖尿病的一个更隐匿的亚组与表型2型糖尿病区分开来。
Ann N Y Acad Sci. 2008 Dec;1150:263-6. doi: 10.1196/annals.1447.037.
5
[Study on the postive frequency and distribution of glutamic acid decarboxylase antibody in phenotypic type 2 diabetec patients].[2型糖尿病表型患者谷氨酸脱羧酶抗体阳性率及分布研究]
Zhonghua Liu Xing Bing Xue Za Zhi. 2005 Oct;26(10):800-3.
6
GAD antibodies in probands and their relatives in a cohort clinically selected for Type 2 diabetes.在一组因2型糖尿病而进行临床选择的先证者及其亲属中的谷氨酸脱羧酶抗体
Diabet Med. 2006 Aug;23(8):834-8. doi: 10.1111/j.1464-5491.2006.01915.x.
7
High prevalence of antibodies to glutamic acid decarboxylase in comparison to islet cell antibodies in patients with long-standing insulin-dependent diabetes mellitus.与长期胰岛素依赖型糖尿病患者的胰岛细胞抗体相比,谷氨酸脱羧酶抗体的高患病率。
Res Commun Mol Pathol Pharmacol. 1996 Apr;92(1):43-52.
8
Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria.奥地利终末期肾病及接受透析治疗的糖尿病患者中成人隐匿性自身免疫性糖尿病的患病率及谷氨酸脱羧酶抗体频率
Nephrol Dial Transplant. 2005 Mar;20(3):559-65. doi: 10.1093/ndt/gfh662. Epub 2005 Jan 25.
9
Prevalence and clinical characteristics of insulin-treated, anti-GAD-positive, type 2 diabetic subjects in an outpatient clinical department of a Dutch teaching hospital.荷兰一家教学医院门诊临床科室中接受胰岛素治疗、抗谷氨酸脱羧酶抗体阳性的2型糖尿病患者的患病率及临床特征
Neth J Med. 2006 Apr;64(4):114-8.
10
Clinical characteristics of patients with the initial diagnosis of NIDDM with positivity for antibodies to glutamic acid decarboxylase.初诊为2型糖尿病且谷氨酸脱羧酶抗体呈阳性患者的临床特征
Exp Clin Endocrinol Diabetes. 1997;105(6):327-30. doi: 10.1055/s-0029-1211773.

引用本文的文献

1
Infection with SARS-CoV-2 can cause pancreatic impairment.感染 SARS-CoV-2 可能会导致胰腺损伤。
Signal Transduct Target Ther. 2024 Apr 12;9(1):98. doi: 10.1038/s41392-024-01796-2.
2
The worldwide prevalence of latent autoimmune diabetes of adults among adult-onset diabetic individuals: a systematic review and meta-analysis.成人隐匿性自身免疫性糖尿病在成年发病糖尿病患者中的全球流行率:系统评价和荟萃分析。
Endocrine. 2023 Oct;82(1):28-41. doi: 10.1007/s12020-023-03424-5. Epub 2023 Jul 10.
3
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes.
瘦型/正常体重 2 型糖尿病的病理生理学的现有知识。
Int J Mol Sci. 2022 Dec 30;24(1):658. doi: 10.3390/ijms24010658.
4
Local Antibiotic Delivery Systems in Diabetic Foot Osteomyelitis: A Brief Review.局部抗生素递送系统在糖尿病足骨髓炎中的应用:简要综述。
Rev Diabet Stud. 2021 Nov 1;17(2):75-81. doi: 10.1900/RDS.2021.17.75.
5
Clinical Features, Biochemical Profile, and Response to Standard Treatment in Lean, Normal-Weight, and Overweight/Obese Indian Type 2 Diabetes Patients.瘦、正常体重和超重/肥胖的印度 2 型糖尿病患者的临床特征、生化特征及对标准治疗的反应。
Rev Diabet Stud. 2021 Nov 1;17(2):68-74. doi: 10.1900/RDS.2021.17.68.
6
Association of obesity with hypertension and type 2 diabetes mellitus in India: A meta-analysis of observational studies.印度肥胖与高血压及2型糖尿病的关联:观察性研究的荟萃分析
World J Diabetes. 2018 Jan 15;9(1):40-52. doi: 10.4239/wjd.v9.i1.40.
7
Challenges in diagnosis and management of diabetes in the young.青少年糖尿病诊断与管理中的挑战。
Clin Diabetes Endocrinol. 2016 Nov 10;2:18. doi: 10.1186/s40842-016-0036-6. eCollection 2016.
8
Antibodies against glutamic acid decarboxylase and indices of insulin resistance and insulin secretion in nondiabetic adults: a cross-sectional study.非糖尿病成年人中谷氨酸脱羧酶抗体与胰岛素抵抗及胰岛素分泌指标:一项横断面研究。
Diabetes Metab Syndr Obes. 2017 May 8;10:179-185. doi: 10.2147/DMSO.S137216. eCollection 2017.
9
Clinical and biochemical profile of lean type 2 diabetes mellitus.瘦型2型糖尿病的临床和生化特征
Indian J Endocrinol Metab. 2011 Jul;15(Suppl 1):S40-3. doi: 10.4103/2230-8210.83061.